LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 48.36 | 17.25 | 3205 | 4390 | 0.7300 | 0.9228 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 48.36 | 17.25 | 2 | 4390 | 0.0005 | -0.2363 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 48.36 | 17.25 | 3689 | 4390 | 0.8403 | 0.9569 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 50.33 | 17.25 | 6 | 4651 | 0.0013 | -0.1226 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 50.33 | 17.25 | 3445 | 4651 | 0.7407 | 0.9270 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 50.33 | 17.25 | 2688 | 4651 | 0.5779 | 0.8687 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 50.33 | 17.25 | 3414 | 4651 | 0.7340 | 0.9249 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 50.33 | 17.25 | 5 | 4651 | 0.0011 | -0.1422 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 50.33 | 17.25 | 3884 | 4651 | 0.8351 | 0.9559 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 52.30 | 17.25 | 6 | 4798 | 0.0013 | -0.1220 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 52.30 | 17.25 | 3687 | 4798 | 0.7684 | 0.9361 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 52.30 | 17.25 | 2938 | 4798 | 0.6123 | 0.8827 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 52.30 | 17.25 | 3641 | 4798 | 0.7588 | 0.9332 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 52.30 | 17.25 | 4 | 4798 | 0.0008 | -0.1647 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 52.30 | 17.25 | 4110 | 4798 | 0.8565 | 0.9622 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 54.27 | 17.25 | 33 | 4884 | 0.0068 | 0.0829 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 54.27 | 17.25 | 3906 | 4884 | 0.7997 | 0.9459 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 54.27 | 17.25 | 3335 | 4884 | 0.6828 | 0.9085 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 54.27 | 17.25 | 3800 | 4884 | 0.7780 | 0.9393 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 54.27 | 17.25 | 5 | 4884 | 0.0010 | -0.1411 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 54.27 | 17.25 | 4401 | 4884 | 0.9011 | 0.9746 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 56.24 | 17.25 | 10 | 4929 | 0.0020 | -0.0647 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 56.24 | 17.25 | 4122 | 4929 | 0.8363 | 0.9566 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 56.24 | 17.25 | 3512 | 4929 | 0.7125 | 0.9186 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 56.24 | 17.25 | 4044 | 4929 | 0.8204 | 0.9521 | MN20160310_N02 | K07 |